Exploring functional genomics for the development of novel intervention strategies against tuberculosis

International Journal of Medical Microbiology

Volumn 297, Issue 7-8, 2007, Pages 559-567

  Rachman, Helmy ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

DNA array; Gene expression profile; Mycobacterium tuberculosis; Protein networks

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; DNA VACCINE; ETHAMBUTOL; ISONIAZID; LIVE VACCINE; PYRAZINAMIDE; RIFAMPICIN; TRANSCRIPTOME; TUBERCULIN;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHROMATOGRAPHY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA MICROARRAY; DRUG DESIGN; DRUG EFFICACY; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENE SEQUENCE; HOST; HUMAN; INTERVENTION STUDY; LUNG TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RADIOGRAPHY; SERODIAGNOSIS; SHORT SURVEY; SKIN TEST; TUBERCULOSIS; VACCINE PRODUCTION;

EID: 35348901516     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.03.003     Document Type: Short Survey

References (95)

1. Agger E.M., and Andersen P. Tuberculosis subunit vaccine development: on the role of interferon-gamma. Vaccine 19 (2001) 2298-2302
2. Agger E.M., and Andersen P. A novel TB vaccine; towards a strategy based on our understanding of BCG failure. Vaccine 21 (2002) 7-14
3. Asselineau C., Asselineau J., Laneelle G., and Laneelle M.A. The biosynthesis of mycolic acids by mycobacteria: current and alternative hypotheses. Prog. Lipid Res. 41 (2002) 501-523
4. Barry III C.E., and Mdluli K. Drug sensitivity and environmental adaptation of mycobacterial cell wall components. Trends Microbiol. 4 (1996) 275-281
5. Barry III C.E., Lee R.E., Mdluli K., Sampson A.E., Schroeder B.G., Slayden R.A., and Yuan Y. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37 (1998) 143-179
6. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., and Small P.M. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 (1999) 1520-1523
7. Biketov S., Mukamolova G.V., Potapov V., Gilenkov E., Vostroknutova G., Kell D.B., Young M., and Kaprelyants A.S. Culturability of Mycobacterium tuberculosis cells isolated from murine macrophages: a bacterial growth factor promotes recovery. FEMS Immunol. Med. Microbiol. 29 (2000) 233-240
8. Bishai W. Lipid lunch for persistent pathogen. Nature 406 (2000) 683-685
9. Boshoff H.I., Reed M.B., Barry III C.E., and Mizrahi V. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113 (2003) 183-193
10. Boshoff H.I., Myers T.G., Copp B.R., McNeil M.R., Wilson M.A., and Barry III C.E. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279 (2004) 40174-40184
11. Brady G. Expression profiling of single mammalian cells - small is beautiful. Yeast 17 (2000) 211-217
12. Brandt L., and Orme I. Prospects for new vaccines against tuberculosis. Biotechniques 33 (2002) 1098, 1100, 1102
13. Brennan P.J., and Nikaido H. The envelope of mycobacteria. Annu. Rev. Biochem. 64 (1995) 29-63
14. Christie J.D., and Callihan D.R. The laboratory diagnosis of mycobacterial diseases: challenges and common sense. Clin. Lab. Med. 15 (1995) 279-306
15. Clemens D.L., and Horwitz M.A. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J. Exp. Med. 184 (1996) 1349-1355
16. Codecasa L., Mantegani P., Galli L., Lazzarin A., Scarpellini P., and Fortis C. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection. J. Clin. Microbiol. 44 (2006) 1944-1950
17. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
18. Cole K.A., Krizman D.B., and Emmert-Buck M.R. The genetics of cancer - a 3D model. Nat. Genet. 21 (1999) 38-41
19. Cooper A.M., and Flynn J.L. The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 7 (1995) 512-516
20. Dandekar T., Snel B., Huynen M., and Bork P. Conservation of gene order: a fingerprint of proteins that physically interact. Trends Biochem. Sci. 23 (1998) 324-328
21. Dannenberg Jr. A.M. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology 191 (1994) 461-473
22. Dodson J.M., Charles P.T., Stenger D.A., and Pancrazio J.J. Quantitative assessment of filter-based cDNA microarrays: gene expression profiles of human T-lymphoma cell lines. Bioinformatics 18 (2002) 953-960
23. Donoghue H.D., Spigelman M., Greenblatt C.L., Lev-Maor G., Bar-Gal G.K., Matheson C., Vernon K., Nerlich A.G., and Zink A.R. Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA. Lancet Infect. Dis. 4 (2004) 584-592
24. Duine J.A. Thiols in formaldehyde dissimilation and detoxification. Biofactors 10 (1999) 201-206
25. Dye C. Global epidemiology of tuberculosis. Lancet 367 (2006) 938-940
26. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., Weiss R.A., and Liotta L.A. Laser capture microdissection. Science 274 (1996) 998-1001
27. In: Espinal M.A. (Ed). The global situation of MDR-TB. Tuberculosis (Edinburgh) 83 (2003) 44-51
28. Fellenberg K., Hauser N.C., Brors B., Neutzner A., Hoheisel J.D., and Vingron M. Correspondence analysis applied to microarray data. Proc. Natl. Acad. Sci. USA 98 (2001) 10781-10786
29. Fenhalls G., Stevens-Muller L., Warren R., Carroll N., Bezuidenhout J., Van Helden P., and Bardin P. Localisation of mycobacterial DNA and mRNA in human tuberculous granulomas. J. Microbiol. Methods 51 (2002) 197-208
30. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
31. Flynn J.L., and Chan J. Tuberculosis: latency and reactivation. Infect. Immun. 69 (2001) 4195-4201
32. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178 (1993) 2249-2254
33. Frei R. Current methods in rapid diagnosis of tuberculosis. Schweiz. Med. Wochenschr. 123 (1993) 147-152 (in German)
34. Gagneux S., Burgos M.V., DeRiemer K., Encisco A., Munoz S., Hopewell P.C., Small P.M., and Pym A.S. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathogenesis 2 (2006) e61
35. Gingeras T.R., Ghandour G., Wang E., Berno A., Small P.M., Drobniewski F., Alland D., Desmond E., Holodniy M., and Drenkow J. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res. 8 (1998) 435-448
36. Gordon S.V., Brosch R., Billault A., Garnier T., Eiglmeier K., and Cole S.T. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32 (1999) 643-655
37. Grode L., Seiler P., Baumann S., Hess J., Brinkmann V., Nasser E.A., Mann P., Goosmann C., Bandermann S., Smith D., Bancroft G.J., Reyrat J.M., van S.D., Raupach B., and Kaufmann S.H. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis Bacille Calmette-Guerin mutants that secrete listeriolysin. J. Clin. Invest. 115 (2005) 2472-2479
38. Guleria I., Teitelbaum R., McAdam R.A., Kalpana G., Jacobs Jr. W.R., and Bloom B.R. Auxotrophic vaccines for tuberculosis. Nat. Med. 2 (1996) 334-337
39. Gutierrez M.C., Brisse S., Brosch R., Fabre M., Omais B., Marmiesse M., Supply P., and Vincent V. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathogenesis 1 (2005) e5
40. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., and Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119 (2004) 753-766
41. Herrler M. Use of SMART-generated cDNA for differential gene expression studies. J. Mol. Med. 78 (2000) B23
42. Hess J., and Kaufmann S.H. Development of live recombinant vaccine candidates against tuberculosis. Scand. J. Infect. Dis. 33 (2001) 723-724
43. Hess, J., Szalay, G., Miko, D., Gentschev, I., Goebel, W., Ladel, C.H., Kaufmann, S.H., 1994. Vaccination strategies using viable carrier systems against intracellular pathogens. Behring Inst. Mitt. 67-79.
44. Hess J., Grode L., Hellwig J., Conradt P., Gentschev I., Goebel W., Ladel C., and Kaufmann S.H. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol. Med. Microbiol. 27 (2000) 283-289
45. Hughes A.J., Hutchinson P., Gooding T., Freezer N.J., Holdsworth S.R., and Johnson P.D. Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin. Exp. Immunol. 142 (2005) 132-139
46. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., DeWitt C.M., Orme I.M., Baldwin S., D'Souza C., Drowart A., Lozes E., Vandenbussche P., Van Vooren J.P., Liu M.A., and Ulmer J.B. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2 (1996) 893-898
47. Im J.G., Itoh H., Lee K.S., and Han M.C. CT-pathology correlation of pulmonary tuberculosis. Crit Rev. Diagn. Imag. 36 (1995) 227-285
48. Jarlier V., and Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123 (1994) 11-18
49. Kato-Maeda M., Bifani P.J., Kreiswirth B.N., and Small P.M. The nature and consequence of genetic variability within Mycobacterium tuberculosis. J. Clin. Invest. 107 (2001) 533-537
50. Kato-Maeda M., Rhee J.T., Gingeras T.R., Salamon H., Drenkow J., Smittipat N., and Small P.M. Comparing genomes within the species Mycobacterium tuberculosis. Genome Res. 11 (2001) 547-554
51. Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat. Med. 6 (2000) 955-960
52. Kaufmann S.H. Envisioning future strategies for vaccination against tuberculosis. Nat. Rev. Immunol. 6 (2006) 699-704
53. Kozal M.J., Shah N., Shen N., Yang R., Fucini R., Merigan T.C., Richman D.D., Morris D., Hubbell E., Chee M., and Gingeras T.R. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat. Med. 2 (1996) 753-759
54. Lambert, P.A., 2002. Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. Symp. Ser. Soc. Appl. Microbiol. 46S-54S.
55. Landowski C.P., Godfrey H.P., Bentley-Hibbert S.I., Liu X., Huang Z., Sepulveda R., Huygen K., Gennaro M.L., Moy F.H., Lesley S.A., and Haak-Frendscho M. Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J. Clin. Microbiol. 39 (2001) 2418-2424
56. Louise R., Skjot V., Agger E.M., and Andersen P. Antigen discovery and tuberculosis vaccine development in the post-genomic era. Scand. J. Infect. Dis. 33 (2001) 643-647
57. Luo L., Salunga R.C., Guo H., Bittner A., Joy K.C., Galindo J.E., Xiao H., Rogers K.E., Wan J.S., Jackson M.R., and Erlander M.G. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat. Med. 5 (1999) 117-122
58. Ma Q., Zhao X., Eddine A.N., Geerlof A., Li X., Cronan J.E., Kaufmann S.H., and Wilmanns M. The Mycobacterium tuberculosis LipB enzyme functions as a cysteine/lysine dyad acyltransferase. Proc. Natl. Acad. Sci. USA 103 (2006) 8662-8667
59. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., and Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178 (1996) 1274-1282
60. Marcotte E.M., Pellegrini M., Ng H.L., Rice D.W., Yeates T.O., and Eisenberg D. Detecting protein function and protein-protein interactions from genome sequences. Science 285 (1999) 751-753
61. Marcotte E.M., Pellegrini M., Thompson M.J., Yeates T.O., and Eisenberg D. A combined algorithm for genome-wide prediction of protein function. Nature 402 (1999) 83-86
62. Matz M., Shagin D., Bogdanova E., Britanova O., Lukyanov S., Diatchenko L., and Chenchik A. Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res. 27 (1999) 1558-1560
63. Menzies D. What does tuberculin reactivity after bacille Calmette-Guerin vaccination tell us?. Clin. Infect. Dis. 31 Suppl. 3 (2000) S71-S74
64. Mohanty B.K., and Kushner S.R. Polyadenylation of Escherichia coli transcripts plays an integral role in regulating intracellular levels of polynucleotide phosphorylase and RNase E. Mol. Microbiol. 45 (2002) 1315-1324
65. Mostowy S., and Behr M.A. Comparative genomics in the fight against tuberculosis: diagnostics, epidemiology, and BCG vaccination. Am. J. Pharmacogenomics 2 (2002) 189-196
66. Olakanmi O., Schlesinger L.S., Ahmed A., and Britigan B.E. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools: impact of interferon-gamma and hemochromatosis. J. Biol. Chem. 277 (2002) 49727-49734
67. Overbeek R., Fonstein M., D'Souza M., Pusch G.D., and Maltsev N. The use of gene clusters to infer functional coupling. Proc. Natl. Acad. Sci. USA 96 (1999) 2896-2901
68. Pabon C., Modrusan Z., Ruvolo M.V., Coleman I.M., Daniel S., Yue H., and Arnold Jr. L.J. Optimized T7 amplification system for microarray analysis. Biotechniques 31 (2001) 874-879
69. Park H., Song E.J., Song E.S., Lee E.Y., Kim C.M., Jeong S.H., Shin J.H., Jeong J., Kim S., Park Y.K., Bai G.H., and Chang C.L. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44 (2006) 1619-1624
70. Pellegrini M., Marcotte E.M., Thompson M.J., Eisenberg D., and Yeates T.O. Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. Proc. Natl. Acad. Sci. USA 96 (1999) 4285-4288
71. Rachman H., Kim N., Ulrichs T., Baumann S., Pradl L., Eddine A.N., Bild M., Rother M., Kuban R.J., Lee J.S., Hurwitz R., Brinkmann V., Kosmiadi G.A., and Kaufmann S.H. Critical role of methylglyoxal and AGE in mycobacteria-induced macrophage apoptosis and activation. PLoS ONE 1 (2006) e29
72. Rachman H., Lee J.S., Angermann J., Kowall J., and Kaufmann S.H. Reliable amplification method for bacterial RNA. J. Biotechnol. 126 (2006) 61-68
73. Rachman H., Strong M., Schaible U., Schuchhardt J., Hagens K., Mollenkopf H., Eisenberg D., and Kaufmann S.H. Mycobacterium tuberculosis gene expression profiling within the context of protein networks. Microbes Infect. 8 (2006) 747-757
74. Rachman H., Strong M., Ulrichs T., Grode L., Schuchhardt J., Mollenkopf H., Kosmiadi G.A., Eisenberg D., and Kaufmann S.H. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect. Immun. 74 (2006) 1233-1242
75. Rajajee S. Tuberculin and BCG tests. Indian J. Pediatr. 67 (2000) S9-S13
76. Rindi L., Lari N., Gil M.G., and Garzelli C. Oligo(dT)-primed synthesis of cDNA by reverse transcriptase in mycobacteria. Biochem. Biophys. Res. Commun. 248 (1998) 216-218
77. Rott R., Zipor G., Portnoy V., Liveanu V., and Schuster G. RNA polyadenylation and degradation in cyanobacteria are similar to the chloroplast but different from E. coli. J. Biol. Chem. 278 (2003) 15771-15777
78. Salama N., Guillemin K., McDaniel T.K., Sherlock G., Tompkins L., and Falkow S. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl. Acad. Sci. USA 97 (2000) 14668-14673
79. Salin H., Vujasinovic T., Mazurie A., Maitrejean S., Menini C., Mallet J., and Dumas S. A novel sensitive microarray approach for differential screening using probes labelled with two different radioelements. Nucleic Acids Res. 30 (2002) e17
80. Sambandamurthy V.K., Wang X., Chen B., Russell R.G., Derrick S., Collins F.M., Morris S.L., and Jacobs Jr. W.R. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat. Med. 8 (2002) 1171-1174
81. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
82. Schutze K., and Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat. Biotechnol. 16 (1998) 737-742
83. Shalon D., Smith S.J., and Brown P.O. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6 (1996) 639-645
84. Shinnick T.M. Diagnostic test needs for evaluating antituberculosis vaccines. Clin. Infect. Dis. 30 Suppl. 3 (2000) S276-S278
85. Stears R.L., Getts R.C., and Gullans S.R. A novel, sensitive detection system for high-density microarrays using dendrimer technology. Physiol. Genomics 3 (2000) 93-99
86. Strong M., Graeber T.G., Beeby M., Pellegrini M., Thompson M.J., Yeates T.O., and Eisenberg D. Visualization and interpretation of protein networks in Mycobacterium tuberculosis based on hierarchical clustering of genome-wide functional linkage maps. Nucleic Acids Res. 31 (2003) 7099-7109
87. Strong M., Mallick P., Pellegrini M., Thompson M.J., and Eisenberg D. Inference of protein function and protein linkages in Mycobacterium tuberculosis based on prokaryotic genome organization: a combined computational approach. Genome Biol. 4 (2003) R59
88. Sugawara I., Yamada H., Kazumi Y., Doi N., Otomo K., Aoki T., Mizuno S., Udagawa T., Tagawa Y., and Iwakura Y. Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. J. Med. Microbiol. 47 (1998) 871-877
89. Talaat A.M., Hunter P., and Johnston S.A. Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis. Nat. Biotechnol. 18 (2000) 679-682
90. Troesch A., Nguyen H., Miyada C.G., Desvarenne S., Gingeras T.R., Kaplan P.M., Cros P., and Mabilat C. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J. Clin. Microbiol. 37 (1999) 49-55
91. Ulrichs T., Kosmiadi G.A., Trusov V., Jorg S., Pradl L., Titukhina M., Mishenko V., Gushina N., and Kaufmann S.H. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J. Pathol. 204 (2004) 217-228
92. Waddell S.J., Stabler R.A., Laing K., Kremer L., Reynolds R.C., and Besra G.S. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinburgh) 84 (2004) 263-274
93. Wilson M., DeRisi J., Kristensen H.H., Imboden P., Rane S., Brown P.O., and Schoolnik G.K. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl. Acad. Sci. USA 96 (1999) 12833-12838
94. Wilson J.W., Bean P., Robins T., Graziano F., and Persing D.H. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay. J. Clin. Microbiol. 38 (2000) 3022-3028
95. Young D., and Dye C. The development and impact of tuberculosis vaccines. Cell 124 (2006) 683-687